News for Tarsus Pharmaceuticals, Inc. (TARS)

Published at

May 5, 2025 7:02 PM

by insidermonkey.com

positive

positive

11 Best Breakout Stocks to Buy According to Analysts

Stock markets have been on edge in response to the US President's aggressive trade war that has resulted in trade tariffs aimed at settling the trade deficit.

TARS GEO1.MX GEO CBZ

Read more →
Published at

May 5, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

\n\nPR NewswireGREENFIELD, Ind., May 5, 2025\n\n\n\nGREENFIELD, Ind., May 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the s

TIF TARS ELAN MSCL.SN

Read more →
Published at

Apr 24, 2025 11:21 PM

by manilatimes.net

positive

positive

Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

**media[605048]**

TARS

Read more →
Published at

Mar 21, 2025 4:36 PM

by gurufocus.com

positive

positive

TANG CAPITAL MANAGEMENT LLC Increases Stake in Acelyrin Inc

On March 10, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant stock transaction involving Acelyrin Inc. The firm added 1,526,365 sha

TARS MIRM.MX MIRM GXE.DE GLPGF GLPG.AS GLPG EOLS AUPH AUP.TO 0K16.L

Read more →
Published at

Mar 13, 2025 6:51 AM

by seekingalpha.com

positive

positive

Tarsus prices $125M stock offering (TARS:NASDAQ)

Tarsus Pharmaceuticals (TARS) priced an upsized underwritten public offering of 2.81M shares of its common stock at a public offering price of $44.50 per share.

TARS

Read more →
Published at

Mar 13, 2025 4:00 AM

by gurufocus.com

positive

positive

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. ( TARS) (the ”Company” or ”Tarsus”) today announced the pricing of an

TARS

Read more →
Published at

Mar 13, 2025 3:10 AM

by manilatimes.net

positive

positive

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering

**media[564970]**

TARS

Read more →
Published at

Mar 12, 2025 11:00 PM

by gurufocus.com

positive

positive

Tarsus Announces Proposed $100.0 Million Public Offering

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. ( TARS) (the ”Company” or ”Tarsus”) today announced the commencement o

TARS

Read more →
Published at

Mar 12, 2025 9:31 PM

by manilatimes.net

positive

positive

Tarsus Announces Proposed $100.0 Million Public Offering

**media[564868]**

TARS

Read more →
Published at

Mar 12, 2025 9:12 PM

by benzinga.com

positive

positive

Tarsus Announces Proposed $100.0 Million Public Offering - Tarsus Pharmaceuticals (NASDAQ:TARS)

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) (the

TARS

Read more →
Published at

Mar 7, 2025 12:01 AM

by gurufocus.com

positive

positive

Tarsus Pharmaceuticals Inc (TARS) to Participate in Barclays Global Healthcare Conference

Summary Tarsus Pharmaceuticals Inc (TARS), a company dedicated to revolutionizing treatment through proven science and new technology, announced its participati

TARS

Read more →
Published at

Mar 6, 2025 11:22 PM

by manilatimes.net

positive

positive

Tarsus to Participate in Upcoming Investor Conference

**media[559707]**

TARS

Read more →
Published at

Feb 28, 2025 8:20 AM

by gurufocus.com

positive

positive

Decoding Tarsus Pharmaceuticals Inc (TARS): A Strategic SWOT Insight

Comprehensive SWOT analysis based on Tarsus Pharmaceuticals Inc's latest SEC 10-K filing.Financial overview highlights a market capitalization of approximately

TARS

Read more →
Published at

Feb 28, 2025 3:05 AM

by gurufocus.com

positive

positive

TANG CAPITAL MANAGEMENT LLC Increases Stake in Acelyrin Inc

On February 25, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring an additional 2,000,000 shares of Acelyrin

TARS MIRM.MX MIRM GXE.DE GLPGF GLPG.AS GLPG EOLS AUPH AUP.TO 0K16.L

Read more →
Published at

Feb 26, 2025 11:00 PM

by gurufocus.com

mixed

mixed

STAAR Surgical Announces Leadership Transition

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction

TARS STAA FRGAP MNKKQ MNK

Read more →
Published at

Feb 26, 2025 8:05 AM

by gurufocus.com

positive

positive

Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Expansions

Net Product Sales: $180.1 million for the full year 2024.Q4 Product Sales: $66.4 million.Bottles Dispensed: 163,000 bottles for the full year 2024.Gross Margin

TARS

Read more →
Published at

Feb 26, 2025 6:06 AM

by gurufocus.com

positive

positive

Q4 2024 Tarsus Pharmaceuticals Inc Earnings Call Transcript

Feb 25, 2025 / 01:00PM GMTOperator Good morning and welcome to Tarsus this year in 2024 financial results conference call. As a reminder, this call is being rec

TARS

Read more →
Published at

Feb 25, 2025 10:10 PM

by seekingalpha.com

neutral

neutral

Tarsus Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:TARS)

The following slide deck was published by Tarsus Pharmaceuticals, Inc.

TARS

Read more →
Published at

Feb 25, 2025 4:05 PM

by gurufocus.com

positive

positive

Tarsus Pharmaceuticals Inc (TARS) Reports Strong Financial Results for 2024

Tarsus Pharmaceuticals Inc (TARS) announced its financial results for the fourth quarter and full-year 2024, showcasing significant growth in net product sales

TARS

Read more →
Published at

Feb 25, 2025 2:40 PM

by zacks.com

positive

positive

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Tops Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of 11.76% and 12.33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

TARS

Read more →